Table 2 Percentage of stromal TILs in the group of 30 patients before and after recurrence (columns 2,3, respectively) and in 11 patients with DCIS without local recurrence (Column 4)
Initial scores of stromal TILs in 30 patients with initial DCIS before recurrence | Scores of stromal TILs in 30 patients after detection of invasive recurrence | Scores of stromal TILs in 11 patients without recurrence | |
|---|---|---|---|
Median (range) | 10% (1–45) | 15% (2–70) | 8% (1–35) |
Scores of TILs depending on biological subtypes | |||
HER2-positive | 5% (1–25) | 5% (2–40) | 8% (1–35) |
Luminal HER2-negative | 7% (1–45) | 20% (5–70) | 10% (2–20) |
Scores of TILs depending on estrogen receptor | |||
ER-positive | 7% (1–45) | 20% (2–70) | 8% (2–25) |
ER-negative | 10% (1–25) | 5% (2–40) | 5% (1–35) |